Wellness

Can Ozempic Treat Fatty Liver Disease? A Doctor Explains the Liver Health Benefits

Find out how semaglutide compares to the new fatty liver medication Rezdiffra

Comments
TOP STORIES

Ozempic is well-known for its ability to manage type 2 diabetes and aid weight loss. . But as more research emerges, additional health benefits of the GLP-1 drug are being uncovered. Previous studies have shown the medication may be able to help protect vision and slow cognitive aging. Now, new research suggests it may even help manage fatty liver disease. We asked a doctor to weigh in on how the medication can help reduce fat in the liver and who might qualify for a prescription. 

How Ozempic helps manage fatty liver disease 

Ozempic’s active ingredient is semaglutide, a GLP-1 receptor agonist that manages blood sugar by increasing insulin levels, slowing gastric emptying and controlling appetite. 

This drug can significantly benefit patients with fatty liver disease, especially in cases of nonalcoholic fatty liver disease (NAFLD). by reducing liver fat. It works primarily through aiding weight loss and improving insulin sensitivity, explains Edmond Hakimi, DO, internal medicine physician and Medical Director at Wellbridge.

“Since NAFLD is closely tied to obesity and metabolic issues like insulin resistance, semaglutide addresses these root causes,” he explains. “Additionally, semaglutide lowers blood sugar levels, which can further ease the metabolic strain on the liver.”

Clinical studies reveal that semaglutide can lower liver fat content and, in some cases, even reduce inflammation and early fibrosis (scarring of the liver), adds Dr. Hakimi. 

Indeed, a review published in Diabetes & Metabolic Syndrome: Clinical Research & Reviews studied participants with NAFLD or non-alcoholic steatohepatitis (NASH) who took semaglutide for 24 weeks. The results? Participants experienced decreased levels of enzymes that occur when the liver is damaged or diseased and saw significant improvements in liver fat content, liver stiffness, hemoglobin levels and lipid profiles. 

And a separate study in The New England Journal of Medicine found that 59 percent of patients with NASH who took a high dose of semaglutide for 72 weeks saw an improvement in their condition without worsening of fibrosis. And 43 percent of study participants saw an improvement in fibrosis.  

Is Ozempic approved to treat fatty liver? 

Currently, Ozempic is only FDA-approved to treat type 2 diabetes (Ozempic), while Wegovy (another brand-name semaglutide) is approved for chronic weight management in people with obesity or who are overweight.

“While not officially approved for fatty liver disease in individuals without these conditions, some doctors prescribe semaglutide off-label for patients with NAFLD or NASH, particularly if they are at high risk of liver complications,” explains Dr. Hakimi. “If you have fatty liver but don’t have diabetes or obesity, your eligibility for semaglutide will depend on your overall health and your doctor’s clinical judgement.” 

Insurance doesn’t cover Ozempic for fatty liver 

It’s important to note that insurance companies are becoming increasingly strict and very rarely cover for Ozempic without a type 2 diabetes diagnosis. That means if you have fatty liver but not type 2 diabetes, your insurance company will likely not cover the drug. 

For Wegovy insurance coverage, you’ll need to show evidence of a body mass index (BMI) of 30 or greater, a BMI of 27 to 29.9 with at least one weight-related comorbid condition, or a BMI of 27 or greater and established cardiovascular disease. Again, insurance providers are unlikely to cover Wegovy if you have fatty liver but none of the qualifying conditions mentioned above.

How Ozempic compares to Rezdiffra

The FDA recently approved a drug called Rezdiffra, the first and only medication specifically for fatty liver treatment in people with NASH and moderate to advanced liver scarring. The active ingredient in Rezdiffra (remestirom) works in a different way than Ozempic.

“When compared to specific fatty liver medications like Rezdiffra, semaglutide works more broadly by addressing systemic metabolic issues, whereas Rezdiffra specifically targets liver fat metabolism and fibrosis,” says Dr. Hakimi. “Rezdiffra is a thyroid hormone receptor-beta agonist designed to reduce liver fat and fibrosis directly, making it potentially more effective for advanced cases of fatty liver. Semaglutide, however, provides dual benefits for individuals with fatty liver who also struggle with obesity or diabetes.” 

Understanding the side effects of Ozempic 

If your doctor prescribes Ozempic for fatty liver, it’s important to be aware of the potential side effects. In the Diabetes & Metabolic Syndrome: Clinical Research & Reviews study, risk of serious adverse gastrointestinal events was high following semaglutide treatment compared to the placebo group. The most common complaints were nausea and vomiting, indigestion, decreased appetite, constipation and diarrhea as well as gallbladder-related diseases.

“For most people with fatty liver, semaglutide is safe and can improve liver health, but there are a few considerations to keep in mind,” says Dr. Hakimi. “In rare cases, semaglutide may cause an elevation in liver enzymes, so regular monitoring is essential for those with significant liver damage or advanced fibrosis. If you have existing liver conditions, especially cirrhosis, it’s crucial to discuss potential risks with your doctor to ensure semaglutide is appropriate for you.”

This content is not a substitute for professional medical advice or diagnosis. Always consult your physician before pursuing any treatment plan.

 

Conversation

All comments are subject to our Community Guidelines. Woman's World does not endorse the opinions and views shared by our readers in our comment sections. Our comments section is a place where readers can engage in healthy, productive, lively, and respectful discussions. Offensive language, hate speech, personal attacks, and/or defamatory statements are not permitted. Advertising or spam is also prohibited.

Use left and right arrow keys to navigate between menu items. Use right arrow key to move into submenus. Use escape to exit the menu. Use up and down arrow keys to explore. Use left arrow key to move back to the parent list.

Already have an account?